ZIPRECRUITER, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data ZIPRECRUITER, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2019	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	430	418	741	905	646	474	449
Cost of revenue	54.8	54.2	79.6	86.3	64.3	50.2	48.3
Gross profit	375	364	662	818	581	424	401
Research and development	65.4	69.4	110	128	142	135	125
Selling and marketing	276	191	411	484	265	216	228
General and administrative	39.5	39	149	109	94.9	72	67.6
Operating expenses	381	300	670	721	502	423	420
Operating income	-6.32	64.4	-8.39	97.2	79.4	1.26	-19.4
Interest expense	0.58	1.04	0.92	28.5	29.4	29.6	29.6
Interest income			0	4.96	19.9	22.5	18
Other non-operating income	0.56	-0.1	-0.88	-23.1	-8.89	-7.76	-11.3
Pre-tax income	-5.76	64.3	-9.28	74.1	70.6	-6.5	-30.6
Income tax	0.59	-21.7	-12.9	12.6	21.5	6.36	2.38
Net income	-6.35	86	3.6	61.5	49.1	-12.9	-33
EBITDA	2.63	74.4	1.07	108	91.1	13.6	-6.9
EPS, basic	-0.13	0.79	0.02	0.54	0.49	-0.13	-0.37
EPS, diluted	-0.13	0.70	0.02	0.51	0.46	-0.13	-0.37
Shares, basic (weighted)	79.3	79.7	102	114	101	98.6	89.9
Shares, diluted (weighted)	79.3	94.2	115	121	106	98.6	89.9

Balance sheet

	FY2019	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	35.5	115	255	227	283	218	188
Short-term investments			0	343	237	287	221
Receivables		21	41.7	44.4	27.2	23.5	25.7
Other current assets		5.46	9.72	12.6	9.85	10.1	11.1
Total current assets		145	311	632	562	544	449
Property, plant and equipment		5.04	8.7	8.1	6.21	4.89	4.08
Lease right-of-use assets		22.5	18.5	12.2	8.74	6.01	9.72
Goodwill		1.72	1.72	1.72	1.7	8.5	8.52
Intangible assets		11.2	13.7	15.8	0	5.34	3.37
Other non-current assets		0.11	3.34	1.04	0.76	0.47	0.2
Total assets		212	399	715	660	664	570
Accounts payable		13.5	24.9	21.2	11.8	10.5	9.12
Accrued liabilities		38.8	86.2	69.1	41.7	43.5	36.6
Deferred revenue		15.1	23.3	19.6	12.9	10.8	9.73
Total current liabilities		71.5	143	130	84.9	81.6	70.9
Long-term debt		25.4	0	542	543	544	545
Lease liabilities		25.1	19.2	13	8.72	6.29	10.7
Other non-current liabilities		3.61	1.58	1.7	15	19.1	20.6
Total liabilities		126	164	686	651	651	647
Total debt		25.4	0	542	543	544	545
Paid-in capital		21.7	303	35.9	14.5	32.4	0
Retained earnings		-71.4	-67.8	-6.29	-5.53	-18.4	-76.6
Treasury stock		-0.64	-0.64	-0.64	-0.64	-0.64	-0.64
Other comprehensive income			0	-0.37	0.01	0.06	0.03
Shareholders' equity	-122	-50.3	235	28.6	8.37	13.4	-77.2
Total equity	-122	-50.3	235	28.6	8.37	13.4	-77.2
Total liabilities and equity		212	399	715	660	664	570
Shares outstanding							71.4

Cash flow statement

	FY2019	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-6.35	86	3.6	61.5	49.1	-12.9	-33
Depreciation and amortization	8.94	9.95	9.46	10.7	11.6	12.3	12.5
Stock-based compensation	6.74	5.75	107	77	84.2	64.4	47.6
Deferred income tax	-0.06	-22.9	-14.9	-0.62	-18.4	-15.5	-1.84
Change in receivables	-9.85	1.32	-22.4	-6.67	14.4	3.69	-3.35
Change in payables	0.75	5.12	11.2	-3.58	-9.34	-1.38	-1.37
Cash from operations	-2.14	88	144	129	103	45.7	11
Capital expenditures	-2.52	-1.36	-6.08	-2.69	-0.92	-0.92	-1.08
Acquisitions				0	0	-12	0
Purchases of investments		0	0	-367	-421	-633	-525
Sales and maturities of investments		0	0	0.86	0	0	0.98
Cash from investing	-10.4	-7.37	-13.3	-351	107	-62	65.1
Stock issued	0.95	2.37	18.5	4.75	4.27	1.94	2.84
Share buybacks	0	-19	-2.75	-339	-148	-40.3	-102
Cash from financing	0.95	-1.63	9.28	195	-154	-48.4	-106
Net change in cash	-11.6	79	140	-27.2	55.7	-64.6	-30.4
Free cash flow	-4.65	86.7	138	126	102	44.8	9.88
Interest paid	0.58	0.7	0.34	14.6	28.1	28.1	28.2
Income taxes paid	0.88	1	1.94	14.7	25.6	18	4.06

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $3.51 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	89.1%	Gross profit / revenue.
Operating margin	0.3%	Operating income / revenue.
EBITDA margin	3.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	10.3%	Pre-tax income / revenue.
Net margin	6.2%	Net income / revenue.
FCF margin	4.7%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	4.9%	Cash from operations / revenue.
Effective tax rate	39.7%	Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)	8.7%	Net income / average total assets.
Return on invested capital (ROIC)	1.1%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	24.7%	Research and development expense / revenue.
Stock-based pay / revenue	8.0%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.2%	Capital expenditures / revenue.
D&A / revenue	2.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-5.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-20.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	1.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-5.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-21.2%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	1.9%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-1,634.0%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-150.9%	EBITDA vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-76.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-56.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-34.1%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-78.0%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-57.2%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-35.2%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-674.8%	Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y	-14.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-7.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	21.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-8.8%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-9.5%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.9%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	3.03x	Current assets / current liabilities.
Quick ratio	2.82x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	2.45x	(Cash + short-term investments) / current liabilities.
Debt / assets	78.8%	Total debt / total assets.
Liabilities / assets	110.5%	Total liabilities / total assets.
Net debt	$79.5M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	5.85x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	0.05x	Operating income / interest expense.
Working capital	$144.5M	Current assets - current liabilities.
Goodwill and intangibles / assets	2.7%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$42.3M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.41x	Revenue / average total assets.
Fixed asset turnover	117x	Revenue / average property, plant and equipment.
Receivables turnover	17.1x	Revenue / average receivables.
Days sales outstanding	21 days	365 x average receivables / revenue.
Days payables	116 days	365 x average accounts payable / cost of revenue.
FCF conversion	76.3%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	3.8%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.34	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$5.47	Revenue / diluted weighted shares.
FCF per share	$0.26	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.27	Cash from operations / diluted weighted shares.
Book value per share	-$0.41	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$0.51	Tangible book value / shares outstanding.
Cash per share	$2.10	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	128.7%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$288.6M	Share price x shares outstanding.
Enterprise value	$368.1M	Market cap + total debt - cash - short-term investments.
P/E	10.3x	Market cap / net income. Only when net income is positive.
P/S	0.64x	Market cap / revenue.
P/FCF	13.5x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	13.0x	Market cap / cash from operations, when positive.
EV/Sales	0.81x	Enterprise value / revenue.
EV/EBIT	235x	Enterprise value / operating income, when both are positive.
EV/EBITDA	27.1x	Enterprise value / EBITDA, when both are positive.
EV/FCF	17.2x	Enterprise value / free cash flow, when both are positive.
FCF yield	7.4%	Free cash flow / market cap.
Earnings yield	9.7%	Net income / market cap (the inverse of P/E).
Shareholder yield	9.5%	(Dividends paid + share buybacks) / market cap.

What was ZIPRECRUITER, INC.'s revenue in fiscal 2025?

ZIPRECRUITER, INC. reported revenue of $449.0M for fiscal 2025, 5.3% lower than the year before.

Was ZIPRECRUITER, INC. profitable in fiscal 2025?

No. It reported a net loss of $33.0M.

How much free cash flow did ZIPRECRUITER, INC. generate in fiscal 2025?

Cash from operations of $11.0M minus capital expenditures of $1.1M left free cash flow of $9.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ZIPRECRUITER, INC.